title: [The value of GnRH agonist treatments before hysteroscopic septum dissection].
abstract: In a retrospective study was investigated, whether a GnRH-analogue-pre-treatment has advantages during the hysteroscopic septum dissection in infertile and sterile patients with a uterus septus. The results show, that a GnRH-analogue-pre-treatment has no positive effect on intraoperative data (time of surgery, fluid deficit), the rate of complications, the postoperative anatomical results (residual septus) and the pregnancy rate. A GnRH-analogue-pre-treatment for a hysteroscopic septum dissection is not generally necessary. The surgery should be carried out in the proliferative phase of the menstrual cycle.
authors.affiliation: Klinik für Frauenheilkunde und Geburtshilfe, Ernst-Moritz-Arndt-Universität Greifswald.
authors.forename: T
authors.initials: T
authors.lastname: Römer
mesh_terms: D000328:Adult; D004724:Endoscopy; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage*; D006801:Humans; D015907:Hysteroscopy; D007247:Infertility, Female / Q000209:etiology; D011247:Pregnancy; D011292:Premedication; D012189:Retrospective Studies; D014599:Uterus / Q000002:abnormalities* / Q000601:surgery
chemical_list: D007987:Gonadotropin-Releasing Hormone
vernacular_title: Zum Wert der GnRH-Agonistenvorbehandlung vor der hysterokopischen Septumdissektion.